Sunstone Life Science Ventures divests its holding in Arcoma AB
Sunstone announces that one hundred percent of the holding in Arcoma AB have been sold in a structured block sale.
Sunstone has been a major owner in Arcoma since 2010 and is proud of what the company has achieved in delivering world-class digital radiographic systems. The investment was placed in Sunstone Life Science Venture Funds II established in 2007. The fund is under liquidation and the divestment is a step in the process to return proceeds to the investors in the Fund and is in no way related to the current status or progress of Arcoma.
Press inquiries should be adressed to:
Recent Comments